Integra LifeSciences Holdings Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 4,427

Employees

  • Stock Symbol
  • IART

Stock Symbol

  • Investments
  • 53

  • Share Price
  • $13.55
  • (As of Thursday Closing)

Integra LifeSciences Holdings General Information

Description

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Contact Information

Formerly Known As
Integra LifeSciences
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1100 Campus Road
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Stock Exchange
NAS
Corporate Office
  • 1100 Campus Road
  • Princeton, NJ 08540
  • United States
+1 (609)

Integra LifeSciences Holdings Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Integra LifeSciences Holdings Stock Performance

As of 19-Nov-2026, Integra LifeSciences Holdings’s stock price is $13.55. Its current market cap is $1.05B with 77.8M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.55 $13.86 $8.70 - $20.49 $1.05B 77.8M 1.04M $0.17

Integra LifeSciences Holdings Financials Summary

As of 30-Sep-2026, Integra LifeSciences Holdings has a trailing 12-month revenue of $1.66B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,040,931 2,705,401 3,461,915 4,818,305
Revenue 1,656,786 1,635,245 1,610,527 1,541,573
EBITDA 250,721 (343,821) 179,955 238,756
Net Income 13,013 (516,474) (6,944) 67,741
Total Assets 3,507,798 3,602,001 4,037,424 3,781,988
Total Debt 0 2,033,184 1,984,563 1,681,682
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Integra LifeSciences Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Integra LifeSciences Holdings‘s full profile, request access.

Request a free trial

Integra LifeSciences Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for re
Surgical Devices
Princeton, NJ
4,427 As of 2025

Lewisville, TX
 

Warsaw, IN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Integra LifeSciences Holdings Competitors (17)

One of Integra LifeSciences Holdings’s 17 competitors is Orthofix Medical, a Formerly PE-Backed company based in Lewisville, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orthofix Medical Formerly PE-Backed Lewisville, TX
Zimmer Biomet Holdings Corporation Warsaw, IN
Shoulder Innovations Venture Capital-Backed Holland, MI
Medtronic Corporation Minneapolis, MN
Teleflex Corporation Wayne, PA
You’re viewing 5 of 17 competitors. Get the full list »

Integra LifeSciences Holdings Patents

Integra LifeSciences Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026080590-A1 Method and matrix for brain tissue repair Pending 11-Oct-2024
AU-2025220232-A1 Medical device with antibiotic and anti-adherence properties Pending 05-Feb-2024
WO-2025170968-A1 Medical device with antibiotic and anti-adherence properties Pending 05-Feb-2024
AU-2025208278-A1 Collagen matrices of varying charge and cross-linking density Pending 12-Jan-2024
US-20250228949-A1 Collagen matrices of varying charge and cross-linking density Pending 12-Jan-2024 A61K47/42
To view Integra LifeSciences Holdings’s complete patent history, request access »

Integra LifeSciences Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Integra LifeSciences Holdings Investments & Acquisitions (53)

Integra LifeSciences Holdings’s most recent deal was a Corporate Asset Purchase with Medtronic plc (Durepair Dural Regeneration Matrix) for . The deal was made on 02-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Medtronic plc (Durepair Dural Regeneration Matrix) 02-Oct-2024 Corporate Asset Purchase Buildings and Property
Integra Lifesciences (Manufacturing Facility in Plainsboro, New Jersey) 01-Oct-2024 Corporate Asset Purchase Buildings and Property
Acclarent 01-Apr-2024 Merger/Acquisition Surgical Devices
Surgical Innovation Associates 06-Dec-2022 Merger/Acquisition Surgical Devices
ACell 20-Jan-2021 Merger/Acquisition Surgical Devices
You’re viewing 5 of 53 investments and acquisitions. Get the full list »

Integra LifeSciences Holdings ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

21.03 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Integra LifeSciences Holdings’s complete esg history, request access »

Integra LifeSciences Holdings Exits (6)

Integra LifeSciences Holdings’s most recent exit was on 24-Feb-2017 from Derma Sciences. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Derma Sciences 24-Feb-2017 Completed
Avraham Pharma 25-Feb-2016 Completed
  • 6 buyers
Avraham Pharma 17-Sep-2014 Completed
  • 5 buyers
SeaSpine Holdings 23-May-2011 Completed
Welch Allyn 01-May-2010 Merger/Acquisition Completed
You’re viewing 5 of 6 exits. Get the full list »

Integra LifeSciences Holdings Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Integra Spine Akron, OH 1998
Miltex Dental York, PA
NMT Medical (Three Product Lines) Plainsboro Center, NJ

Integra LifeSciences Holdings FAQs

  • When was Integra LifeSciences Holdings founded?

    Integra LifeSciences Holdings was founded in 1989.

  • Where is Integra LifeSciences Holdings headquartered?

    Integra LifeSciences Holdings is headquartered in Princeton, NJ.

  • What is the size of Integra LifeSciences Holdings?

    Integra LifeSciences Holdings has 4,427 total employees.

  • What industry is Integra LifeSciences Holdings in?

    Integra LifeSciences Holdings’s primary industry is Surgical Devices.

  • Is Integra LifeSciences Holdings a private or public company?

    Integra LifeSciences Holdings is a Public company.

  • What is Integra LifeSciences Holdings’s stock symbol?

    The ticker symbol for Integra LifeSciences Holdings is IART.

  • What is the current stock price of Integra LifeSciences Holdings?

    As of 19-Nov-2026 the stock price of Integra LifeSciences Holdings is $13.55.

  • What is the current market cap of Integra LifeSciences Holdings?

    The current market capitalization of Integra LifeSciences Holdings is $1.05B.

  • What is Integra LifeSciences Holdings’s current revenue?

    The trailing twelve month revenue for Integra LifeSciences Holdings is $1.66B.

  • Who are Integra LifeSciences Holdings’s competitors?

    Orthofix Medical, Zimmer Biomet Holdings, Shoulder Innovations, Medtronic, and Teleflex are some of the 17 competitors of Integra LifeSciences Holdings.

  • What is Integra LifeSciences Holdings’s annual earnings per share (EPS)?

    Integra LifeSciences Holdings’s EPS for 12 months was $0.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process